Search Result

Pathways Recommended:	PI3K/Akt/mTOR

No matches for "

3,3(acute)-Diindolylmethane

" within the MedChemExpress (MCE) catalog. Here are the results you might be looking for.

By Targets:	Aminopeptidase (1) Androgen Receptor (1) Antibiotic (1) Apoptosis (2) Arenavirus (2) Bacterial (3) Biochemical Assay Reagents (1) E3 Ligase Ligand-Linker Conjugates (2) EGFR (1) ERK (1) Fluorescent Dye (1) Fungal (1) GCGR (1) GPR88 (2) HCV (1) HDAC (1) Histone Methyltransferase (1) Isotope-Labeled Compounds (4) MicroRNA (12) Microtubule/Tubulin (1) p38 MAPK (1) Parasite (1) Phosphatase (2) Phosphodiesterase (PDE) (1) Phospholipase (2) PI3K (3) Potassium Channel (1) PROTAC Linkers (1) PROTACs (1) Ras (1) Sodium Channel (1)
By Research Areas:	Cancer (20) Cardiovascular Disease (2) Infection (8) Inflammation/Immunology (4) Metabolic Disease (7) Neurological Disease (6)
Click Chemistry:	PROTAC Synthesis (1) Azide (1)

Inhibitors & Agonists

Fluorescent Dye

Peptides

Inhibitory Antibodies

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Targets Recommended: STK33

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-124871

LASV inhibitor 3.3	Arenavirus	Infection
LASV inhibitor 3.3 is a Lassa fever virus (LASV) inhibitor. LASV inhibitor 3.3 binds with LASV glycoprotein (GP) and promotes virus membrane fusion and infection. LASV inhibitor 3.3 can be used for LASV infection research .

HY-123966A

MY33-3 hydrochloride	Phosphatase	Neurological Disease
MY33-3 hydrochloride is a potent and selective inhibitor of receptor protein tyrosine phosphatase (RPTP)β/ζ, with an IC₅₀ of ~0.1 μM. MY33-3 hydrochloride also inhibits PTP-1B (IC₅₀ ~0.7 μM). MY33-3 hydrochloride can reduce ethanol consumption and alleviate Sevoflurane-induced neuroinflammation and cognitive dysfunction ^[3].

HY-123966

MY33-3	Phosphatase
MY33-3 is a potent and selective inhibitor of receptor protein tyrosine phosphatase (RPTP)β/ζ, with an IC₅₀ of ~0.1 μM. MY33-3 also inhibits PTP-1B (IC₅₀ ~0.7 μM). MY33-3 can reduce ethanol consumption and alleviate Sevoflurane-induced neuroinflammation and cognitive dysfunction ^[3].

HY-P2625

GLP-2(3-33) 1 Publications Verification	GCGR	Metabolic Disease
GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC₅₀=5.8 nM) .

HY-P5576

Aurein 3.3

Antibiotic Bacterial Infection Cancer

Aurein 3.3 is an antibiotic antimicrobial peptide. Aurein 3.3 also has anticancer activity .

Aurein 3.3	Antibiotic Bacterial	Infection Cancer
Aurein 3.3 is an antibiotic antimicrobial peptide. Aurein 3.3 also has anticancer activity .

HY-147898

PI3K-IN-33	PI3K Apoptosis	Cancer
PI3K-IN-33 (Compound 6e) is a highly selective *PI3K* inhibitor with IC₅₀ values of 11.73, 6.09 and 11.18 μM for PI3K-α、PI3K-β and PI3K-δ , respectively. PI3K-IN-33 arrests cell cycle at G2/M phase and induces apoptosis. PI3K-IN-33 can be used in leukemia research .

HY-RI04356

rno-miR-33-3p inhibitor	MicroRNA
rno-miR-33-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-33-3p inhibitor rno-miR-33-3p inhibitor

HY-RI04356A

rno-miR-33-3p antagomir	MicroRNA
rno-miR-33-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-33-3p antagomir rno-miR-33-3p antagomir

HY-R04356

rno-miR-33-3p mimic	MicroRNA	Cancer
rno-miR-33-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

rno-miR-33-3p mimic rno-miR-33-3p mimic

HY-R04356A

rno-miR-33-3p agomir	MicroRNA
rno-miR-33-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-33-3p agomir rno-miR-33-3p agomir

HY-RI00702A

hsa-miR-33a-3p antagomir	MicroRNA
hsa-miR-33a-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-33a-3p antagomir hsa-miR-33a-3p antagomir

HY-RI00704A

hsa-miR-33b-3p antagomir	MicroRNA
hsa-miR-33b-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-33b-3p antagomir hsa-miR-33b-3p antagomir

HY-R00702

hsa-miR-33a-3p mimic	MicroRNA	Cancer
hsa-miR-33a-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-33a-3p mimic hsa-miR-33a-3p mimic

HY-R00704

hsa-miR-33b-3p mimic	MicroRNA	Cancer
hsa-miR-33b-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-33b-3p mimic hsa-miR-33b-3p mimic

HY-R00702A

hsa-miR-33a-3p agomir	MicroRNA
hsa-miR-33a-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-33a-3p agomir hsa-miR-33a-3p agomir

HY-R00704A

hsa-miR-33b-3p agomir	MicroRNA
hsa-miR-33b-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-33b-3p agomir hsa-miR-33b-3p agomir

HY-RI00702

hsa-miR-33a-3p inhibitor	MicroRNA
hsa-miR-33a-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-33a-3p inhibitor hsa-miR-33a-3p inhibitor

HY-RI00704

hsa-miR-33b-3p inhibitor	MicroRNA
hsa-miR-33b-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-33b-3p inhibitor hsa-miR-33b-3p inhibitor

HY-128812A

cIAP1 Ligand-Linker Conjugates 11 Hydrochloride E3 ligase Ligand-Linker Conjugates 33 Hydrochloride	E3 Ligase Ligand-Linker Conjugates	Cancer
cIAP1 Ligand-Linker Conjugates 11 Hydrochloride incorporates an IAP ligand for the E3 ubiquitin ligase, and a PROTAC linker. cIAP1 Ligand-Linker Conjugates 11 Hydrochloride can be used to design SNIPERs .

HY-128812

cIAP1 Ligand-Linker Conjugates 11 E3 ligase Ligand-Linker Conjugates 33	E3 Ligase Ligand-Linker Conjugates	Cancer
cIAP1 Ligand-Linker Conjugates 11 incorporates an IAP ligand for the E3 ubiquitin ligase, and a PROTAC linker. cIAP1 Ligand-Linker Conjugates 11 can be used to design SNIPERs .

HY-P2625S

GLP-2(3-33) (Leu-13C6,15N)	Isotope-Labeled Compounds	Metabolic Disease
GLP-2(3-33) (Leu- ¹³C₆, ¹⁵N) is ¹³C and ¹⁵N labeled GLP-2(3-33) (HY-P2625). GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC₅₀=5.8 nM).

HY-108370

N33-TEG-COOH N3-TEG-COOH; 14-Azido-3,6,9,12-tetraoxatetradecanoic acid	PROTAC Linkers	Cancer
N33-TEG-COOH (N3-TEG-COOH) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs . N33-TEG-COOH is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

HY-P2625S1

GLP-2(3-33) (Leu-13C6,15N) (TFA)	Isotope-Labeled Compounds	Metabolic Disease
GLP-2(3-33) (Leu- ¹³C₆, ¹⁵N) TFA is ¹³C and ¹⁵N labeled GLP-2(3-33) (HY-P2625). GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC₅₀=5.8 nM).

HY-147919

Antifungal agent 33	Fungal	Infection
Antifungal agent 33 (compound 4e) is a potent antifungal agent. Antifungal agent 33 exhibits remarkable antifungal activity against C. albicans, with a MIC of 16 μg/mL. Antifungal agent 33 shows potent inhibitory activity against Lanosterol 14α-demethylase (CYP51), with an IC₅₀ of 0.19 μg/mL .

HY-139749

Antibacterial agent 33

Bacterial Cancer

Antibacterial agent 33, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .

Antibacterial agent 33	Bacterial	Cancer
Antibacterial agent 33, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .

HY-115947

Anticancer agent 33	Others	Cancer
Anticancer agent 33 (compound 3), a Squamocin and Bullatacin derivative, is a potent anticancer agent. Anticancer agent 33 shows high potency to inhibit 4T1 breast cancer cell line (A549, HeLa, HepG2 and MCF-7 cells) growth with IC₅₀s of 1.9-5.4 µM .

HY-149900

Antiviral agent 33	Biochemical Assay Reagents	Infection
Antiviral agent 33 (compound 1c) is a double-stranded DNA (dsDNA) virus inhibitor with IC₅₀ values of 0.0790 and 0.1572 µM for VACV and AdV5, respectively. Antiviral agent 33 also has potential for oral administration .

HY-149856

Tubulin inhibitor 33	Microtubule/Tubulin Apoptosis	Cancer
Tubulin inhibitor 33, a tubulin polymerization inhibitor, inhibits tubulin polymerization in a dose-dependent manner with an IC₅₀ of 9.05 μM. Tubulin inhibitor 33 has antitumor effects and induces cell apoptosis that can be used for antitumor research .

HY-D2095

Medical fluorophore 33	Fluorescent Dye	Cancer
Medical fluorophore 33 is a novel quinoline-isoquinoline salt. Medical fluorophore 33 exhibits a strong fluorescent signal, good microsomal stability and high biocompatibility in vivo. Medical fluorophore 33 has antitumor activity in colorectal cancer mice .

HY-155354

Antimalarial agent 33	Parasite	Infection
Antimalarial agent 33 (compound 5g) has antiplasmodial activity against erythrocytic and hepatic stages of Plasmodium with an EC₅₀ of 1.1 μM for K1 P. falciparum strain. Antimalarial agent 33 demonstrats enhanced microsomal stability (T_1/2=29 min). Antimalarial agent 33 has no significant cytotoxicity against primary hepatocytes .

HY-151921

Anti-inflammatory agent 33	p38 MAPK	Inflammation/Immunology
Anti-inflammatory agent 33 is a potent p38α inhibitor. Anti-inflammatory agent 33 inhibits NO production. Anti-inflammatory agent 33 inhibits LPS-induced iNOS, COX-2, p-p38α, p-MK2 protein expression. Anti-inflammatory agent 33 shows anti-inflammatory activity .

HY-142490

KRAS G12C inhibitor 33	Ras	Cancer
KRAS G12C inhibitor 33 is a KRAS G12C inhibitor extracted from patent WO2021244603A1, compound 1. KRAS G12C inhibitor 33 can be used for the research of cancer .

HY-135732

SK33	Androgen Receptor	Cancer
SK33, a trifluoromethylated enobosarm analog, is a potent, and tissue selective anti-androgen. SK33reduces androgen receptor (AR) transcriptional activity .

HY-141797

MS33	Histone Methyltransferase PROTACs	Cancer
MS33 is a potent WDR5 degrader, with K_ds of 870 nM and 120 nM for VCB and WDR5, respectively. MS33 induces WDR5 degradation in an E3 ligase VHL, and proteasome-dependent manner. MS33 can be used for the research of acute myeloid leukemia ^[3].

HY-150700

RLX-33	ERK	Metabolic Disease
RLX-33 is a potent, selective and blood-brain barrier (BBB) penetrant relaxin family peptide 3 (RXFP3) antagonist, also blocks relaxin-3-induced ERK1/2 phosphorylation, with IC₅₀ values of 2.36 μM for RXFP3, 7.82 and 13.86 μM for ERK1 and ERK2 phosphorylation, respectively. RLX-33 can block the stimulation of food intake induced by the RXFP3-selective agonist R3/I5 in rats. RLX-33 can be used for the research of metabolic syndrome .

HY-100455

RK-33

1 Publications Verification

RK-33 is an RNA helicase inhibitor against DDX3, and inhibits its helicase activity.
HY-156717

RE-33

Others Inflammation/Immunology

RE-33 is an analgesic compound. RE-33 has blood brain barrier penetration ability .

RK-33 1 Publications Verification
RK-33 is an RNA helicase inhibitor against DDX3, and inhibits its helicase activity.

RE-33	Others	Inflammation/Immunology
RE-33 is an analgesic compound. RE-33 has blood brain barrier penetration ability .

HY-W717329

EC33	Aminopeptidase	Cardiovascular Disease
EC33 is a selective aminopeptidase A (APA) inhibitor. EC33 blocks the pressor response of exogenous Ang II. EC33 does not cross the blood-brain barrier. EC33 has the potential for salt-dependent model of hypertension research .

HY-157802

LTGO-33	Sodium Channel	Neurological Disease
LTGO-33 is a potent and selective voltage-gated sodium channel NaV1.8 inhibitor. LTGO-33 inhibits NaV1.8 in the nM potency range and exhibits over 600-fold selectivity against human NaV1.1-NaV1.7 and NaV1.9. LTGO-33 exhibits state-independent inhibition with similar potencies on channels in the closed and inactivated conformations. LTGO-33 inhibits native TTX-R NaV1.8 currents in non-human primate and human DRG neurons, where it reduces action potential firing. LTGO-33 can be used for pain disorders research .

HY-B1260S1

Cetrimonium-d33 bromide CTAB-d₃₃; Cetyltrimethylammonium-d₃₃ bromide; Hexadecyltrimethylammonium-d₃₃ bromide	Isotope-Labeled Compounds	Others
Cetrimonium-d₃₃ (bromide) is the deuterium labeled Cetrimonium bromide[1]. Cetrimonium bromide (CTAB) is an amine based cationic quaternary surfactant, is one of the components of the topical antiseptic Cetrimide.

HY-W284558S

Sodium hexadecyl sulfate-d33

Sodium hexadecyl sulphate-d₃₃
Isotope-Labeled Compounds Others

Sodium hexadecyl sulfate-d₃₃ is the deuterium labeled Sodium hexadecyl sulfate[1].

Sodium hexadecyl sulfate-d33 Sodium hexadecyl sulphate-d₃₃	Isotope-Labeled Compounds	Others
Sodium hexadecyl sulfate-d₃₃ is the deuterium labeled Sodium hexadecyl sulfate[1].

HY-124775

(S)-C33	Phosphodiesterase (PDE)	Neurological Disease
(S)-C33 is a potent and selective PDE9 (phosphodiesterase-9) inhibitor, with an IC₅₀ of 11 nM. (S)-C33 can be used for central nervous system diseases and diabetes research .

HY-144106

HCV-IN-33

HCV Infection

HCV-IN-33 (Compound (S)-3i) is an HCV entry inhibitor .

HCV-IN-33	HCV	Infection
HCV-IN-33 (Compound (S)-3i) is an HCV entry inhibitor .

HY-P0323

GP(33-41)	Arenavirus	Infection
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2D ^b molecules at the RMA-S (Db Kb) cell surface with a SC₅₀ of 344 nM .

HY-123938

Risovalisib CYH33	PI3K	Cancer
Risovalisib (CYH33) is an orally active, highly selective PI3Kα inhibitor with IC₅₀s of 5.9 nM/598 nM/78.7 nM/225 nM against α/β/δ/γ isoform, respectively. Risovalisib inhibits phosphorylation of Akt, ERK and induces significant G1 phase arrest in breast cancer cells and non-small cell lung cancer (NSCLC) cells. Risovalisib has potent activity against solid tumors ^[3].

HY-112612

RTI-13951-33	GPR88	Neurological Disease
RTI-13951-33 is a potent, selective, and brain-penetrant GPR88 agonist, with an EC₅₀ of 25 nM in GPR88 cAMP functional assay. RTI-13951-33 reduces alcohol reinforcement and intake behaviors in rats .

HY-112612A

RTI-13951-33 hydrochloride 1 Publications Verification	GPR88	Neurological Disease
RTI-13951-33 hydrochloride is a potent, selective, and brain-penetrant GPR88 agonist, with an EC₅₀ of 25 nM in GPR88 cAMP functional assay. RTI-13951-33 hydrochloride reduces alcohol reinforcement and intake behaviors in rats .

HY-120348

ML67-33	Potassium Channel	Cardiovascular Disease Neurological Disease
ML67-33 is a selective activator of temperature- and mechano-sensitive K_2P channels. ML67-33 rapidly and reversibly affects K_2P2.1 (TREK-1) with EC₅₀s of 36.3 μM and 9.7 μM in cell-free and HEK293 cells, respectively .

HY-129944

MJ33-OH	Phospholipase	Inflammation/Immunology
MJ33-OH is a metabolite of MJ33. MJ33 is an active-site-directed, specific, competitive, and reversible phospholipase A2 (PLA2) inhibitor. MJ33 blocks the calcium-independent phospholipase A2 (iPLA2) activity of Prdx6 .

HY-130838

JH-LPH-33	Bacterial	Infection
JH-LPH-33, a sulfonyl piperazine analog, is a potent UDP-2,3-diacylglucosamine pyrophosphate hydrolase LpxH inhibitor. JH-LPH-33 displays outstanding antibiotic activity with a MIC value of 0.66 μg/mL .

Cat. No.	Product Name	Target	Research Area

HY-P2625

GLP-2(3-33) 1 Publications Verification	GCGR	Metabolic Disease
GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC₅₀=5.8 nM) .

HY-P2932

Cholecystokinin Cholecystokinin-33(human); CCK-33(human)	Peptides	Metabolic Disease
Cholecystokinin is a peptide hormone. Cholecystokinin, as a hunger suppressant, inhibits food intake and stimulates the digestion of fat and protein. Cholecystokinin can be used for the research of gastrointestinal system ^[3].

HY-P5576

Aurein 3.3

Antibiotic Bacterial Infection Cancer

Aurein 3.3 is an antibiotic antimicrobial peptide. Aurein 3.3 also has anticancer activity .

HY-P2625S

GLP-2(3-33) (Leu-13C6,15N)	Isotope-Labeled Compounds	Metabolic Disease
GLP-2(3-33) (Leu- ¹³C₆, ¹⁵N) is ¹³C and ¹⁵N labeled GLP-2(3-33) (HY-P2625). GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC₅₀=5.8 nM).

HY-P2625S1

GLP-2(3-33) (Leu-13C6,15N) (TFA)	Isotope-Labeled Compounds	Metabolic Disease
GLP-2(3-33) (Leu- ¹³C₆, ¹⁵N) TFA is ¹³C and ¹⁵N labeled GLP-2(3-33) (HY-P2625). GLP-2(3-33), generated naturally by dipeptidylpeptidase IV (DPPIV), acts as a partial agonist on GLP-2 receptor (EC₅₀=5.8 nM).

HY-P5222

Hexapeptide-33

Peptides Others

Hexapeptide-33 is a bioactive peptide and has been reported used as a cosmetic ingredient .

HY-P1585

Gp100 (25-33), human Hgp100 (25-33)	Peptides	Inflammation/Immunology
Gp100 (25-33), human (Hgp100 (25-33)) is the amino acids 25-33 fragment of the human melanoma antigen. It is a 9-amino acid (AA) epitope restricted by H-2D ^b and recognized by the T cells .

HY-P2506

Gp100 (25-33), mouse Mgp100 (25-33)	Peptides	Cancer
Gp100 (25-33), mouse sequence is found in residues 25 to 33 of the mouse self/tumor antigen glycoprotein (mgp100). Mgp100 is an enzyme involved in pigment synthesis, and the epitope fragment is expressed in both normal melanocytes and melanoma cells .

HY-P3651

Cholecystokinin (26-33) (free acid) CCK (26-33) (free acid)	Peptides	Metabolic Disease
Cholecystokinin (26-33) (CCK (26-33)) free acid is a cholecystokinin (CCK) fragment. Cholecystokinin (26-33) free acid can reduce food intake and gallbladder contraction .

HY-P0323

GP(33-41)	Arenavirus	Infection
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2D ^b molecules at the RMA-S (Db Kb) cell surface with a SC₅₀ of 344 nM .

Species:	Human (21) Rhesus Macaque (3) Mouse (8) Cynomolgus (3)
Tag:	His (24) Tag Free (4) Strep (1) Avi (9) Myc (1) Fc (8)
Source:	HEK293 (30) E. coli (5)

Cat. No.	Compare	Product Name	Species	Source

HY-P73641

	Siglec-3/CD33 Protein, Mouse (HEK293) Myeloid Cell Surface Antigen CD33; Siglec-3; gp67; CD33; SIGLEC3	Mouse	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Mouse (HEK293) is the recombinant mouse-derived Siglec-3/CD33 protein, expressed by HEK293 , with tag free. The total length of Siglec-3/CD33 Protein, Mouse (HEK293) is 240 a.a., with molecular weight of ~25.6 kDa.

HY-P73643

	Siglec-3/CD33 Protein, Human (HEK293) Myeloid Cell Surface Antigen CD33; Siglec-3; gp67; CD33; SIGLEC3	Human	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Human (HEK293) is the recombinant human-derived Siglec-3/CD33 protein, expressed by HEK293 , with tag free. The total length of Siglec-3/CD33 Protein, Human (HEK293) is 242 a.a., with molecular weight of ~27.4 kDa.

HY-P73639

	Siglec-3/CD33 Protein, Mouse (HEK293, His) Myeloid Cell Surface Antigen CD33; Siglec-3; gp67; CD33; SIGLEC3	Mouse	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-His labeled tag. The total length of Siglec-3/CD33 Protein, Mouse (HEK293, His) is 240 a.a., with molecular weight of 38-42 kDa.

HY-P73640

	Siglec-3/CD33 Protein, Mouse (HEK293, Fc) Myeloid Cell Surface Antigen CD33; Siglec-3; gp67; CD33; SIGLEC3	Mouse	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Siglec-3/CD33 Protein, Mouse (HEK293, Fc) is 240 a.a., with molecular weight of 55-60 kDa.

HY-P73642

	Siglec-3/CD33 Protein, Human (HEK293, hFc) Myeloid Cell Surface Antigen CD33; Siglec-3; gp67; CD33; SIGLEC3	Human	HEK293
	Siglec-3/CD33 protein is a sialic acid-binding lectin that mediates cell-cell interactions and maintains immune cell quiescence. It prefers α-2,3- and α-2,6-linked glycans with sialic acid. Siglec-3/CD33 Protein, Human (HEK293, hFc) is the recombinant human-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Siglec-3/CD33 Protein, Human (HEK293, hFc) is 242 a.a., with molecular weight (glycosylation form) of 68-80 kDa.

HY-P73644

	Siglec-3/CD33 Protein, Human (HEK293, His) Myeloid Cell Surface Antigen CD33; Siglec-3; gp67; CD33; SIGLEC3	Human	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Human (HEK293, His) is the recombinant human-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-His labeled tag. The total length of Siglec-3/CD33 Protein, Human (HEK293, His) is 242 a.a., with molecular weight of 40-46 kDa.

HY-P77536

	Siglec-3/CD33 Protein, Human (Biotinylated, HEK293, His) Myeloid Cell Surface Antigen CD33; Siglec-3; gp67; CD33; SIGLEC3	Human	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Human (Biotinylated, HEK293, His) is the recombinant human-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-His labeled tag. The total length of Siglec-3/CD33 Protein, Human (Biotinylated, HEK293, His) is 242 a.a., with molecular weight of ~28.2 KDa.

HY-P75651

	Siglec-3/CD33 Protein, Cynomolgus/Rhesus Macaque (HEK293, His) Myeloid Cell Surface Antigen CD33; Siglec-3; gp67; CD33; SIGLEC3	Rhesus Macaque	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Cynomolgus/Rhesus Macaque (HEK293, His) is the recombinant Rhesus Macaque-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-His labeled tag. The total length of Siglec-3/CD33 Protein, Cynomolgus/Rhesus Macaque (HEK293, His) is 233 a.a., with molecular weight of ~45.2 kDa.

HY-P78407

	Siglec-3/CD33 Protein, Human (HEK293, His-Avi) CD33 molecule; CD33; FLJ00391; gp67; Siglec3; Siglec-3; p67	Human	HEK293
	Siglec-3/CD33 protein is a sialic acid-binding lectin that mediates cell-cell interactions and maintains immune cell quiescence. It prefers α-2,3- and α-2,6-linked glycans with sialic acid. Siglec-3/CD33 Protein, Human (HEK293, His-Avi) is the recombinant human-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of Siglec-3/CD33 Protein, Human (HEK293, His-Avi) is 242 a.a., with molecular weight of 52-60 kDa.

HY-P75652

	Siglec-3/CD33 Protein, Cynomolgus/Rhesus Macaque (Biotinylated, HEK293, His) Myeloid Cell Surface Antigen CD33; Siglec-3; gp67; CD33; SIGLEC3	Rhesus Macaque	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Cynomolgus/Rhesus Macaque (Biotinylated, HEK293, His) is the recombinant Rhesus Macaque-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-His labeled tag. The total length of Siglec-3/CD33 Protein, Cynomolgus/Rhesus Macaque (Biotinylated, HEK293, His) is 248 a.a., with molecular weight of ~27.3 kDa.

HY-P701037

	Siglec-3/CD33 Protein, Human (Biotinylated, HEK293, His-Avi) CD33 molecule; CD33; FLJ00391; gp67; Siglec3; Siglec-3; p67	Human	HEK293
	Siglec-3/CD33 protein, a sialic-acid-binding lectin, mediates cell-cell interactions and maintains immune cell quiescence. It prefers alpha-2,3- and more avidly alpha-2,6-linked sialic acid-bearing glycans. Upon ligand engagement, CD33's ITIMs phosphorylate, recruiting PTPN6/SHP-1 and PTPN11/SHP-2. These phosphatases, activated by Src-like kinases, regulate downstream pathways, including the repressive effect on monocyte activation through PI3K. CD33 also forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2, and engages C1QA via its C-terminus, activating inhibitory motifs. Siglec-3/CD33 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived Siglec-3/CD33 protein, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of Siglec-3/CD33 Protein, Human (Biotinylated, HEK293, His-Avi) is 242 a.a., with molecular weight of 48-58 kDa.

HY-P72472

	Siglec-3/CD33 Protein, Human (HEK293, Fc-His) Myeloid Cell Surface Antigen CD33; Sialic Acid-Binding Ig-Like Lectin 3; Siglec-3; gp67; CD33; SIGLEC3	Human	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Human (HEK293, Fc-His) is the recombinant human-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-hFc, C-6*His labeled tag. The total length of Siglec-3/CD33 Protein, Human (HEK293, Fc-His) is 242 a.a., with molecular weight of ~80 kDa.

HY-P78408

	FITC-Labeled Siglec-3/CD33 Protein, Human (HEK293, His-Avi) CD33 molecule; CD33; FLJ00391; gp67; Siglec3; Siglec-3; p67	Human	HEK293
	Siglec-3/CD33 protein is a sialic acid-binding lectin that mediates cell-cell interactions and maintains immune cell quiescence. It prefers α-2,3- and α-2,6-linked glycans with sialic acid. FITC-Labeled Siglec-3/CD33 Protein, Human (HEK293, His-Avi) is the recombinant human-derived FITC-Labeled Siglec-3/CD33 protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of FITC-Labeled Siglec-3/CD33 Protein, Human (HEK293, His-Avi) is 242 a.a., with molecular weight of 48-58 kDa.

HY-P701262

	FITC-Labeled Siglec-3/CD33 Protein, Human (HEK293, Fc) CD33; SIGLEC3; gp67	Human	HEK293
	Siglec-3/CD33 protein is a sialic acid-binding lectin that mediates cell-cell interactions and maintains immune cell quiescence. It prefers α-2,3- and α-2,6-linked glycans with sialic acid. FITC-Labeled Siglec-3/CD33 Protein, Human (HEK293, Fc) is the recombinant human-derived FITC-Labeled Siglec-3/CD33 protein, expressed by HEK293 , with Fc labeled tag. The total length of FITC-Labeled Siglec-3/CD33 Protein, Human (HEK293, Fc) is 242 a.a., with molecular weight of 70-90 kDa.

HY-P78208

	Siglec-15 Protein, Mouse (Biotinylated, HEK293, His) CD33 molecule-like 3; CD33L3; HsT1361; Siglec15; CD33 antigen-like 3; SIGLEC-15	Mouse	HEK293
	Siglec-15 Protein, a Siglec family member and type-1 transmembrane protein, is constitutively expressed in osteoclasts, macrophages and dendritic cells. Siglec-15 plays a pivotal role in the development and differentiation of osteoclastogenesis, inhibiting antigen-specific T cell responses in vitro and in vivo. Siglec-15 Protein, Mouse (Biotinylated, HEK293, His) is the recombinant mouse-derived Siglec-15 protein, expressed by HEK293 , with C-His labeled tag. The total length of Siglec-15 Protein, Mouse (Biotinylated, HEK293, His) is 239 a.a., with molecular weight of 35-43 kDa.

HY-P78353

	Siglec-15 Protein, Cynomolgus (HEK293, His-Avi) CD33 molecule-like 3; CD33L3; HsT1361; Siglec15; CD33 antigen-like 3; SIGLEC-15	Cynomolgus	HEK293
	Siglec-15 Protein, a Siglec family member and type-1 transmembrane protein, is constitutively expressed in osteoclasts, macrophages and dendritic cells. Siglec-15 plays a pivotal role in the development and differentiation of osteoclastogenesis, inhibiting antigen-specific T cell responses in vitro and in vivo. Siglec-15 Protein, Cynomolgus (HEK293, His-Avi) is the recombinant cynomolgus-derived Siglec-15 protein, expressed by HEK293 , with C-His, C-Avi labeled tag. The total length of Siglec-15 Protein, Cynomolgus (HEK293, His-Avi) is 244 a.a., with molecular weight of 33-43 kDa.

HY-P78515

	Siglec-15 Protein, Human (HEK293, His-Avi) CD33 molecule-like 3; CD33L3; HsT1361; Siglec15; CD33 antigen-like 3; SIGLEC-15	Human	HEK293
	Siglec-15 protein plays a crucial role in cellular interactions, selectively binding to sialylated glycoproteins with an affinity for sialic acid residues. Engaging with TYROBP and HCST, it indicates involvement in intricate signaling pathways. This specific recognition of sialylated glycoproteins underscores Siglec-15's significance in mediating immune responses and cellular communication, contributing to the complex network of cellular interactions. Siglec-15 Protein, Human (HEK293, His-Avi) is the recombinant human-derived Siglec-15 protein, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of Siglec-15 Protein, Human (HEK293, His-Avi) is 244 a.a., with molecular weight of 30-38 kDa.

HY-P72473

	Siglec-3/CD33 Protein, Mouse (G236R, HEK293, His) Myeloid Cell Surface Antigen CD33; Sialic Acid-Binding Ig-Like Lectin 3; Siglec-3; gp67; CD33; SIGLEC3	Mouse	HEK293
	Siglec-3/CD33, a sialic-acid-binding lectin, crucially mediates cell-cell interactions and immune cell quiescence. Preferring sialic acid on specific mucins, it forms homodimers, interacting with PTPN6/SHP-1 and PTPN11/SHP-2 upon phosphorylation. CD33 also engages C1QA through its C-terminus, activating CD33 inhibitory motifs. Siglec-3/CD33 Protein, Mouse (G236R, HEK293, His) is the recombinant mouse-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Siglec-3/CD33 Protein, Mouse (G236R, HEK293, His) is 223 a.a., with molecular weight of 30-45 kDa.

HY-P72021

	Siglec-3/CD33 Protein, Human (HEK293, Fc-Myc) Sialic acid-binding Ig-like lectin 3 Siglec-3; gp67; CD33; SIGLEC3	Human	HEK293
	Siglec-3/CD33 protein is a sialic acid-binding lectin that mediates cell-cell interactions and maintains immune cell quiescence. It prefers α-2,3- and α-2,6-linked glycans with sialic acid. Siglec-3/CD33 Protein, Human (HEK293, Fc-Myc) is the recombinant human-derived Siglec-3/CD33 protein, expressed by HEK293 , with C-Myc, C-Fc labeled tag. The total length of Siglec-3/CD33 Protein, Human (HEK293, Fc-Myc) is 242 a.a., with molecular weight of ~92 kDa.

HY-P701036

	Siglec-15 Protein, Cynomolgus (Biotinylated, 263a.a, HEK293, His-Avi) CD33 molecule-like 3; CD33L3; HsT1361; Siglec15; CD33 antigen-like 3; SIGLEC-15	Cynomolgus	HEK293
	The Siglec-15 protein plays a critical role in cellular interactions, selectively binding to sialylated glycoproteins with affinity for sialic acid residues. Binding to TYROBP and HCST suggests involvement in complex signaling pathways. Siglec-15 Protein, Cynomolgus (Biotinylated, 263a.a, HEK293, His-Avi) is the recombinant cynomolgus-derived Siglec-15 protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of Siglec-15 Protein, Cynomolgus (Biotinylated, 263a.a, HEK293, His-Avi) is 263 a.a., with molecular weight of 33-43 kDa.

HY-P71546

	DPYSL3 Protein, Human (His) Collapsin response mediator protein 4; Collapsin response mediator protein 4 long; CRMP 4; CRMP-4; CRMP4; Dihydropyrimidinase like 3; Dihydropyrimidinase related protein 3; Dihydropyrimidinase-related protein 3; DPYL3_HUMAN; DPYSL3; DRP 3; DRP-3; DRP3; LCRMP; TUC4; ULIP 1; ULIP; ULIP-1; ULIP1; UNc 33 like phosphoprotein 1; Unc 33 like phosphoprotein; Unc-33-like phosphoprotein 1	Human	E. coli
	The DPYSL3 protein plays a key role in class 3 semaphorin-triggered signaling, driving cytoskeletal remodeling that is critical for axon guidance, growth cone collapse, and cell migration. As a component of homo- and heterotetramers of CRMP1, DPYSL2, DPYSL4 or DPYSL5, it is intricately associated with related proteins, highlighting its involvement in complex cellular dynamics. DPYSL3 Protein, Human (His) is the recombinant human-derived DPYSL3 protein, expressed by E. coli , with N-His labeled tag. The total length of DPYSL3 Protein, Human (His) is 570 a.a., with molecular weight of ~66.0 kDa.

HY-P7218

	IL-33 Protein, Mouse 4 Publications Verification rMuIL-33; Il33	Mouse	E. coli
	IL-33 Protein, Mouse is a tissue-derived nuclear cytokine from the IL-1 family abundantly expressed in endothelial cells, epithelial cells and fibroblast-like cells, both during homeostasis and inflammation.

HY-P70738

	Siglec-15 Protein, Human (HEK293, mFc) Sialic acid-binding Ig-like lectin 15; Siglec-15; CD33 antigen-like 3; CD33L3	Human	HEK293
	The Siglec-15 protein plays a critical role in cellular interactions, selectively binding to sialylated glycoproteins with affinity for sialic acid residues. Binding to TYROBP and HCST suggests involvement in complex signaling pathways. Siglec-15 Protein, Human (HEK293, mFc) is the recombinant human-derived Siglec-15 protein, expressed by HEK293 , with C-mFc labeled tag. The total length of Siglec-15 Protein, Human (HEK293, mFc) is 244 a.a., with molecular weight of 50-70 kDa.

HY-P70742

	Siglec-15 Protein, Human (HEK293, Fc) Sialic acid-binding Ig-like lectin 15; Siglec-15; CD33 antigen-like 3; CD33L3	Human	HEK293
	The Siglec-15 protein plays a critical role in cellular interactions, selectively binding to sialylated glycoproteins with affinity for sialic acid residues. Binding to TYROBP and HCST suggests involvement in complex signaling pathways. Siglec-15 Protein, Human (HEK293, Fc) is the recombinant human-derived Siglec-15 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Siglec-15 Protein, Human (HEK293, Fc) is 244 a.a., with molecular weight of ~50-80 kDa.

HY-P70743

	Siglec-15 Protein, Cynomolgus (HEK293, His) Sialic acid-binding Ig-like lectin 15; Siglec-15; CD33 antigen-like 3; CD33L3	Cynomolgus	HEK293
	Siglec-15 Protein, a Siglec family member and type-1 transmembrane protein, is constitutively expressed in osteoclasts, macrophages and dendritic cells. Siglec-15 plays a pivotal role in the development and differentiation of osteoclastogenesis, inhibiting antigen-specific T cell responses in vitro and in vivo. Siglec-15 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived Siglec-15 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Siglec-15 Protein, Cynomolgus (HEK293, His) is 244 a.a., with molecular weight of 30-40 kDa.

HY-P70744

	Siglec-15 Protein, Mouse (HEK293, His) Sialic acid-binding Ig-like lectin 15; Siglec-15; CD33 antigen-like 3; CD33L3	Mouse	HEK293
	Siglec-15 Protein, a Siglec family member and type-1 transmembrane protein, is constitutively expressed in osteoclasts, macrophages and dendritic cells. Siglec-15 plays a pivotal role in the development and differentiation of osteoclastogenesis, inhibiting antigen-specific T cell responses in vitro and in vivo. Siglec-15 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Siglec-15 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Siglec-15 Protein, Mouse (HEK293, His) is 239 a.a., with molecular weight of 30-40 kDa.

HY-P72475

	Siglec-15 Protein, Human (HEK293, His) Sialic acid-binding Ig-like lectin 15; Siglec-15; CD33 antigen-like 3; CD33L3	Human	HEK293
	The Siglec-15 protein plays a critical role in cellular interactions, selectively binding to sialylated glycoproteins with affinity for sialic acid residues. Binding to TYROBP and HCST suggests involvement in complex signaling pathways. Siglec-15 Protein, Human (HEK293, His) is the recombinant human-derived Siglec-15 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Siglec-15 Protein, Human (HEK293, His) is 244 a.a., with molecular weight of 30-40 kDa.

HY-P701452

	USP33 Protein, Human USP33; Ubiquitin carboxyl-terminal hydrolase 33; Deubiquitinating enzyme 33; Ubiquitin thioesterase 33; Ubiquitin-specific-processing protease 33; VHL-interacting deubiquitinating enzyme 1; hVDU1	Human	E. coli
	The USP33 protein is a critical deubiquitinase that complexly regulates centrosome duplication, cell migration, and beta-2 adrenergic receptor (ADRB2) recycling. During S and G2/M phases, USP33 deubiquitinates CCP110, stabilizing it and promoting centriole duplication. USP33 Protein, Human is the recombinant human-derived USP33 protein, expressed by E. coli , with tag free. The total length of USP33 Protein, Human is 941 a.a., .

HY-P701453

	USP33 Protein, Human (His, Strep) USP33; Ubiquitin carboxyl-terminal hydrolase 33; Deubiquitinating enzyme 33; Ubiquitin thioesterase 33; Ubiquitin-specific-processing protease 33; VHL-interacting deubiquitinating enzyme 1; hVDU1	Human	E. coli
	The USP33 protein is a critical deubiquitinase that complexly regulates centrosome duplication, cell migration, and beta-2 adrenergic receptor (ADRB2) recycling. During S and G2/M phases, USP33 deubiquitinates CCP110, stabilizing it and promoting centriole duplication. USP33 Protein, Human (His, Strep) is the recombinant human-derived USP33 protein, expressed by E. coli , with N-Strep, N-8*His labeled tag. The total length of USP33 Protein, Human (His, Strep) is 941 a.a., .

HY-P70767

	Siglec-15 Protein, Human (Biotinylated, HEK293, Fc-Avi) Sialic acid-binding Ig-like lectin 15; Siglec-15; CD33 antigen-like 3; CD33L3	Human	HEK293
	The Siglec-15 protein plays a critical role in cellular interactions, selectively binding to sialylated glycoproteins with affinity for sialic acid residues. Binding to TYROBP and HCST suggests involvement in complex signaling pathways. Siglec-15 Protein, Human (Biotinylated, HEK293, Fc-Avi) is the recombinant human-derived Siglec-15 protein, expressed by HEK293 , with C-Avi, C-hFc labeled tag. The total length of Siglec-15 Protein, Human (Biotinylated, HEK293, Fc-Avi) is 244 a.a., with molecular weight of 58-75 kDa.

HY-P74116

	GPA33 Protein, Mouse (HEK293, His) Cell Surface A33 Antigen; Glycoprotein A33; GPA33	Mouse	HEK293
	The GPA33 protein is crucial in cell-cell recognition and signaling, indicating its involvement in fundamental processes. Its influence suggests a significance in mediating interactions and participating in crucial signaling events. Exploring GPA33's mechanisms in recognition and signaling could unveil its broader role in cellular communication and physiological processes. GPA33 Protein, Mouse (HEK293, His) is the recombinant mouse-derived GPA33 protein, expressed by HEK293 , with C-His labeled tag. The total length of GPA33 Protein, Mouse (HEK293, His) is 214 a.a., with molecular weight of 31-39 kDa.

HY-P78450

	GPA33 Protein, Human (HEK293, His-Avi) Glycoprotein A33; GPA33; A33; MGC129986; MGC129987	Human	HEK293
	GPA33 protein potentially plays a role in fundamental cellular processes, specifically in cell-cell recognition and signaling, indicating its involvement in intercellular communication. The exact mechanisms underlying GPA33's role in these processes remain areas of interest, underscoring its potential significance in mediating molecular interactions that contribute to cellular responses. The versatile nature of GPA33 highlights its potential in coordinating cellular recognition events and modulating signaling cascades, emphasizing the need for further exploration to elucidate its specific functions and molecular mechanisms. GPA33 Protein, Human (HEK293, His-Avi) is the recombinant human-derived GPA33 protein, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of GPA33 Protein, Human (HEK293, His-Avi) is 214 a.a., with molecular weight of 28-40 kDa.

HY-P70899

	GPA33 Protein, Human (214a.a, HEK293, His) Cell Surface A33 Antigen; Glycoprotein A33; GPA33	Human	HEK293
	The GPA33 protein may play a role in fundamental cellular processes, particularly in intercellular recognition and signaling, suggesting its involvement in intercellular communication. The exact mechanism by which GPA33 functions in these processes remains an area of interest, emphasizing its potential importance in mediating molecular interactions that contribute to cellular responses. GPA33 Protein, Human (214a.a, HEK293, His) is the recombinant human-derived GPA33 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of GPA33 Protein, Human (214a.a, HEK293, His) is 214 a.a., with molecular weight of 34-37 kDa.

HY-P78136

	GPA33 Protein, Human (Biotinylated, HEK293, His-Avi) Glycoprotein A33; GPA33; A33; MGC129986; MGC129987	Human	HEK293
	The GPA33 protein may play a role in fundamental cellular processes, particularly in intercellular recognition and signaling, suggesting its involvement in intercellular communication. The exact mechanism by which GPA33 functions in these processes remains an area of interest, emphasizing its potential importance in mediating molecular interactions that contribute to cellular responses. GPA33 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived GPA33 protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of GPA33 Protein, Human (Biotinylated, HEK293, His-Avi) is 214 a.a., with molecular weight of 28-40 kDa.

HY-P72548

	IL-33 Protein, Rhesus macaque (His) Interleukin-33; IL-33; IL-1F11; NF-HEV; IL33; C9orf26	Rhesus Macaque	E. coli
	IL-33 is a member of the IL-1 family, known for its significant divergence. IL-33 Protein, Rhesus macaque (His) is the recombinant Rhesus Macaque-derived IL-33 protein, expressed by E. coli , with N-6*His labeled tag. The total length of IL-33 Protein, Rhesus macaque (His) is 159 a.a., with molecular weight of ~21 kDa.

Inquiry Online

Submit your filled information, we will contact you soon.

Salutation:		* Country or Region:
* Applicant Name:		* Organization Name:
* Department:
* Email Address:		* Product Name:
Cat. No.:		* Requested quantity:
* Phone Number:
MCE Japan Authorized Agent:	ナミキ商事株式会社コスモ・バイオ株式会社
Remarks:

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote